Clinical Context
Peer-reviewed veterinary literature continues to shape everyday decision-making for feline patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.
What the Study Evaluated
A study published in BMC veterinary research in 2026 evaluated hypertrophic cardiomyopathy in cats: clinical prevalence, risk factors, and outcomes of arterial thromboembolism in a referral population in Tehran, Iran (2020-2024)..
Key Findings
Hypertrophic cardiomyopathy (HCM) is the most common cardiac disease in cats, yet epidemiological data from Iran are scarce. This study investigated the prevalence of HCM in a referral population of cats in Tehran, Iran, evaluated breed predisposition, characterized clinical findings, and assessed thromboembolic complications in cats referred for suspected cardiac disease. A retrospective multicenter study was conducted using medical records from seven major veterinary hospitals in Tehran between 2020 and 2024. A total of 7,013 cats evaluated for suspected cardiac disease were included. HCM was diagnosed by echocardiographic evidence of...
Why It Matters for Veterinary Professionals
For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for feline patients.
Practical Interpretation
The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.
Clinical Takeaway
Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.
Read the full article here.
List
Add
Please enter a comment